Eli M. Wallace
Impact in
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
- Organic Chemistry top 5%
- Catalytic Alkyne Reactions
- Catalytic C–H Functionalization Methods
- Synthetic Organic Chemistry Methods
Papers in
-
- Asymmetric Synthesis and Catalysis 4
- Synthetic Organic Chemistry Methods 3
-
- Cancer, Hypoxia, and Metabolism 5
- Co-authors
- James Arthur Marshall (3 shared papers)John A. Josey (3 shared papers)Mark A. Wolf (1 shared paper)Xinlin Du (4 shared papers)Kevin M. Koch (6 shared papers)Tammie C. Yeh (3 shared papers)James D. Winkler (4 shared papers)James P. Rizzi (2 shared papers)
- Journals
- Journal of Medicinal Chemistry (4 papers)The Journal of Organic Chemistry (4 papers)Cancer Research (2 papers)European Respiratory Journal (2 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Eli M. Wallace
28 papers receiving 2.4k citations
Eli M. Wallace's Hit Papers
Peers
Comparison fields: 5 of 92
- Cancer Research 677
- Organic Chemistry 667
- Molecular Biology 1.2k
- Oncology 387
- Pulmonary and Respiratory Medicine 393
Countries citing papers authored by Eli M. Wallace
This map shows the geographic impact of Eli M. Wallace's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eli M. Wallace with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eli M. Wallace more than expected).
Fields of papers citing papers by Eli M. Wallace
This network shows the impact of papers produced by Eli M. Wallace. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eli M. Wallace. The network helps show where Eli M. Wallace may publish in the future.
Co-authors
The 25 scholars most cited alongside Eli M. Wallace, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 466 | |
| 2 | On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer models Hit paper breakdown → | 2016 | 361 |
| 3 | 2017 | 320 | |
| 4 | 2019 | 171 | |
| 5 | 1997 | 170 | |
| 6 | 2019 | 138 | |
| 7 | 1995 | 118 | |
| 8 | 2019 | 92 | |
| 9 | 2000 | 91 | |
| 10 | 2011 | 69 | |
| 11 | 1996 | 68 | |
| 12 | 2005 | 62 | |
| 13 | 1998 | 49 | |
| 14 | 1991 | 38 | |
| 15 | 2005 | 35 | |
| 16 | 1997 | 34 | |
| 17 | 2020 | 28 | |
| 18 | 1993 | 25 | |
| 19 | 1992 | 23 | |
| 20 | 2011 | 22 |
About Eli M. Wallace
Eli M. Wallace is a scholar working on Organic Chemistry, Cancer Research, Biotechnology, Cell Biology and Oncology, having authored 29 papers that have together received 2.5k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (5 papers), Asymmetric Synthesis and Catalysis (4 papers), Microtubule and mitosis dynamics (4 papers), Nitric Oxide and Endothelin Effects (4 papers), Melanoma and MAPK Pathways (4 papers), Synthetic Organic Chemistry Methods (3 papers), Cancer Research and Treatments (2 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). The work is most often cited by research in Cancer Research (677 citations), Organic Chemistry (667 citations), Molecular Biology (1.2k citations), Oncology (387 citations) and Pulmonary and Respiratory Medicine (393 citations). Eli M. Wallace has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include James Arthur Marshall, John A. Josey, Mark A. Wolf, Xinlin Du, Kevin M. Koch, Tammie C. Yeh, James D. Winkler, James P. Rizzi, Paul S. Coan and Stefan David Gross. Their work appears in journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry, Cancer Research, European Respiratory Journal and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.